Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
Titel:
Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
Auteur:
Kuemmerle-Deschner, Jasmin B Ramos, Eduardo Blank, Norbert Roesler, Joachim Felix, Sandra D Jung, Thomas Stricker, Kirstin Chakraborty, Abhijit Tannenbaum, Stacey Wright, Andrew M Rordorf, Christiane